New Drug Therapy In The Treatment Of Aids, Cancer

NameProfessorSubjectDecember 4 , 2007New Drug Therapy in the Treatment of help and CancerIntroductionThere atomic number 18 numerous recent do drugs therapies usable in the diametrical hospitals and clinic today . By providing drug therapies on AIDS and back toothcerous neoplastic sickness longanimouss and its familiesa would have to a greater extent hope on the retrieval of the patient s strength . However , not each(prenominal) new drug therapies were authorise by FDA and WHO . There atomic number 18 significant processes that were conducted in the beginning these therapies will completely stick part of the medical healing(predicate) industry . This will encompass the ii different new found therapy intercessions for Aids and cancer - Ixempra (Ixapebilone ) for cancer and Antiretrovival therapy for AIDS /human immu nodeficiency virus . Through the discussion of these both therapies , we could be able to larn the situations and posture of these therapies to the two of the most sensitive illnesses in the worldThe IxabepiloneThe Ixapeboline was created for heart cancer cases . It provides therapy in backup to the usual chemotherapy that was made during the interposition of chest of drawers cancer . This intervention was s last June to avail dumbbell cancer patients in their illness in a more than advanced and proficient way . After quartet month of review , the FDA approved this therapy and would be readily available to the concerned patients as currently as possibleIxabepilone , which will be marketed under the brand attain Ixempra , is indicated for use in cabal with capecitabine in patients who no durable benefit from chemotherapy with anthracyclines (such as doxorubicin or epirubicin ) and taxanes (such as paclitaxel or docetaxel . It can also be apply alone in patients who no longer benefit from an anthracycline , a ! taxane and capecitabine ? -tubulin subunit in particular(prenominal) , but is structurally quite different to the taxanes .

Ixabepilone is an analogue of epothilone B , which means that it is more cheerful for the patients having knocker cancer because it is more radical than the chemotherapy procedure that was make before Its content provides more active elements that would help debar the cyst within the breast areaThis therapy went to different process handle any other therapies that were introduced in the past . The Bristol-Myers Squibb , founder of this therapy conducted several(prenominal) therapeutic su rveys and studies regarding Ixabepilone . They have also conducted an look into that would determine the effectiveness of the therapy to 49 patients within a true area of the domain . Through this investigation and experiment , they beget up into a significant result that would help breast cancer patients to count on this therapy as a supervene upon to the usual chemotherapyIn 49 patients with taxane-resistant metastatic breast cancer , 12 partially responded to treatment with ixabepilone . Among responders in this study , median solvent duration was 10 .4 months median time to progression was 2 .2 months and median pick 7 .9 months . Ixabepilone also proved effective in a study of 23 taxane-napve patients with metastatic breast cancer , where 57 achieved a partial response and 26 stable disease while on ixabepilone therapyThe Antiretroviral TherapyUntil now , many patients of HIV /AIDS are...If you want to get a secure essay, order it on our website: OrderCustomPaper.com

If! you want to get a full essay, visit our page: write my paper